ljm716
Showing 1 - 4 of 4
Advanced HER2-positive Breast Cancer or Gastric Cancer Trial in Worldwide (LJM716, Trastuzumab)
Completed
- Advanced HER2-positive Breast Cancer or Gastric Cancer
- LJM716
- Trastuzumab
-
Boston, Massachusetts
- +10 more
Dec 16, 2020
Esophageal Squamous Cell Carcinoma Trial in Worldwide (LJM716, BYL719, Paclitaxel)
Completed
- Esophageal Squamous Cell Carcinoma
- LJM716
- +4 more
-
Chicago, Illinois
- +12 more
Dec 16, 2020
HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma, HER2
Completed
- HER2 + Breast Cancer, HER2 + Gastric Cancer, Squamous Cell Carcinoma of Head and Neck, Esophageal Squamous Cell Carcinoma
- +4 more
- LJM716
-
Chicago, Illinois
- +7 more
Dec 16, 2020